Acura Pharma Revenue, Profits - ACUR Annual Income Statement

Add to My Stocks
$0.4 $0 (0%) ACUR stock closing price Jun 20, 2018 (Closing)

Financial analysis of Acura Pharma involves more than just checking the Acura Pharma stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for ACUR which shows a YOY revenue decline of -48.02% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. One also needs to look at Acura Pharma assets, operating expenses and Acura Pharma free cash flow. The Acura Pharma profit and loss statement shows revenue of $4.46M for 2016. Revenue has decreased by -48.02% YOY for ACUR stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Acura Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)---------
Acura Pharma Gross Profit
Research & Development Expense4.02M2.6M4.58M4.92M3.72M4.03M7.17M5.67M14.32M
Selling General & Admin Expense6.54M9.32M8.14M9.17M6.01M5.89M8.85M11.66M9.13M
Income Before Depreciation Depletion Amortization-6.55M-4M-12.19M-14.09M-9.73M10.53M-12.72M-13.5M20.98M
Depreciation Depletion Amortization---------
Non Operating Income---------
Interest Expense-1.15M1.21M------
Acura Pharma Pretax Income
Provision for Income Taxes-------2.47M7.28M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-7.38M-4.98M-13.2M-13.9M-9.66M10.38M-12.7M-15.83M14.47M
Extraordinary Items & Discontinued Operations---------
Acura Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS11.87M10.8M9.78M9.55M9.5M9.6M9.41M9.19M9.88M
Average Shares used to compute Basic EPS11.87M10.8M9.78M9.55M9.5M9.5M9.41M9.19M9.14M
Income Before Nonrecurring Items-7.39M-4.99M-13.21M-13.9M-9.67M10.39M-12.71M-15.84M16.87M
Income from Nonrecurring Items---------2.4M
Acura Pharma Earnings Per Share Basic Net
Acura Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.62-0.46-1.35-1.45-1.001.10-1.35-1.751.70
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Acura Pharma stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the Acura Pharma revenue chart, as isn't the case with Acura Pharma indicates a sagging business. One needs to compare the YoY topline or sales growth of ACUR stock with its peers like CPHI stock and SUWN stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. ACUR stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the ACUR income statement, one can check the Acura Pharma historical stock prices to check how the price has moved with time.

Acura Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield